form8k.htm      

UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION 

Washington, D.C. 20549 

———————————— 

FORM 8-K 

CURRENT REPORT 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 

Date of Report (Date of earliest event reported): February 11, 2016 (February 11, 2016) 

———————————— 

PRAXAIR, INC. 

(Exact name of registrant as specified in its charter) 

———————————— 

 [DATA_TABLE_REMOVED]  

39 Old Ridgebury Road 

Danbury, CT 06810-5113 

(Address of principal executive offices) 

(203) 837-2000 

(Registrant’s telephone number, including area code) 

Not Applicable 

(Former name or former address, if changed since last report) 

———————————— 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: 

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) 

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) 

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) 

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) 

Item 8.01. Other Events. 

On February 11, 2016, Praxair, Inc. (the “Company”) issued $275,000,000 aggregate principal amount of 3.200% notes due January 30, 2026 (the “Notes”). The Notes will be part of the same series as the $450,000,000 of 3.200% Notes due 2026 that the Company issued on September 24, 2015. The Notes were priced to yield approximately 2.95% per annum. The Notes were sold pursuant to the Company’s shelf registration statement on Form S-3 filed with the Securities and Exchange Commission (“SEC”) on May 12, 2015. The material terms of the Notes are described in the Company’s prospectus supplement dated February 4, 2016 filed with the SEC on February 5, 2016. 

In connection with the Notes offering, Cahill Gordon & Reindel llp provided certain legal opinions to the Company that are filed as Exhibit 5 to this Form 8-K. 

Item 9.01. Financial Statements and Exhibits. 

(d) Exhibits. The following exhibits are filed herewith: 

 [DATA_TABLE_REMOVED]  

SIGNATURES 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. 

Dated: February 11, 2016 

 [DATA_TABLE_REMOVED]  

Exhibit Index 

 [DATA_TABLE_REMOVED]